https://www.selleckchem.com/pr....oducts/l-nmma-acetat
Strict clinical criteria used by Medicare for germline testing for Lynch syndrome (LS) could lead to missed diagnoses of hereditary cancer syndromes given variable individual and family phenotypes. The aim of this study was to compare rates and spectrum of pathogenic or likely pathogenic (P/LP) variants in LS and other hereditary cancer genes on the basis of meeting Medicare LS testing criteria. Retrospective review of Medicare beneficiaries who had multigene panel testing with an indication of personal or family history of color
Like
Comment
Share
